Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$640M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$501M |
| 3 |
Digital Realty Trust
DLR
|
+$438M |
| 4 |
Intuitive Surgical
ISRG
|
+$437M |
| 5 |
Amazon
AMZN
|
+$420M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$545M |
| 2 |
DexCom
DXCM
|
+$457M |
| 3 |
AT&T
T
|
+$431M |
| 4 |
Palo Alto Networks
PANW
|
+$416M |
| 5 |
Humana
HUM
|
+$394M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.03% |
| 2 | Healthcare | 2.92% |
| 3 | Consumer Discretionary | 1.99% |
| 4 | Financials | 1.93% |
| 5 | Industrials | 1.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
YI
11401
111 Inc
YI
$32.3M
| $65.6K | ﹤0.01% |
2,666
-1,540
| -37% | -$41.3K |
|
|
BIOR
11402
CALL
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
| $65.6K | ﹤0.01% |
1,704
-246
| -13% | -$8.68K |
|
|
STRM
11403
DELISTED
Streamline Health Solutions
STRM
| $65.6K | ﹤0.01% |
3,442
-58
| -2% | -$1.4K |
|
|
VLRS
11404
CALL
Controladora Vuela Compania de Aviacion
VLRS
$906M
| $65.6K | ﹤0.01% |
4,700
-2,000
| -30% | -$25.7K |
|
|
GTHX
11405
CALL
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $65.5K | ﹤0.01% |
26,300
-32,000
| -55% | -$87.4K |
|
|
HOUS
11406
CALL
DELISTED
Anywhere Real Estate
HOUS
| $65.5K | ﹤0.01% |
9,800
-8,600
| -47% | -$51.6K |
|
11407
Rocket Pharmaceuticals Warrant
RCKTW
$117K
| $65.4K | ﹤0.01% |
352,814
-4,636
| -1% | -$849 |
|
11408
PUT
iShares MSCI Australia ETF
EWA
$1.45B
| $65.4K | ﹤0.01% |
2,900
+300
| +12% | +$6.86K |
|
11409
CALL
CION Investment
CION
$370M
| $65.4K | ﹤0.01% |
6,300
+2,100
| +50% | +$20.7K |
|
11410
CALL
LifeMD
LFMD
$166M
| $65.3K | ﹤0.01% |
15,000
+10,800
| +257% | +$24K |
|
|
SUNW
11411
DELISTED
Sunworks, Inc.
SUNW
| $65.1K | ﹤0.01% |
57,576
-324,764
| -85% | -$363K |
|
|
AFIB
11412
DELISTED
Acutus Medical Inc
AFIB
| $65.1K | ﹤0.01% |
73,265
-2,666
| -4% | -$2.26K |
|
11413
CALL
ProShares Short Financials
SEF
$12.9M
| $64.9K | ﹤0.01% |
1,275
-2,975
| -70% | -$157K |
|
|
ONL
11414
CALL
Orion Office REIT
ONL
$164M
| $64.9K | ﹤0.01% |
9,820
+3,280
| +50% | +$20.5K |
|
11415
CALL
Santander
BSBR
$43.2B
| $64.9K | ﹤0.01% |
10,200
-1,100
| -10% | -$6.42K |
|
11416
PUT
Invesco Preferred ETF
PGX
$3.77B
| $64.8K | ﹤0.01% |
5,700
-17,100
| -75% | -$194K |
|
|
INCR
11417
Intercure
INCR
$58.6M
| $64.7K | ﹤0.01% |
38,085
-10,802
| -22% | -$23.7K |
|
11418
Stagwell
STGW
$2.23B
| $64.7K | ﹤0.01% |
8,979
-1,583,521
| -99% | -$10.5M |
|
|
DXYN
11419
DELISTED
Dixie Group Inc
DXYN
| $64.6K | ﹤0.01% |
48,599
-1,418
| -3% | -$1.37K |
|
11420
PUT
Nerdy
NRDY
$90.4M
| $64.6K | ﹤0.01% |
15,500
-14,100
| -48% | -$50.1K |
|
|
IMMP
11421
PUT
Immutep
IMMP
$56M
| $64.6K | ﹤0.01% |
30,600
+13,900
| +83% | +$26K |
|
|
SOL
11422
PUT
DELISTED
Emeren Group
SOL
| $64.4K | ﹤0.01% |
17,000
-5,200
| -23% | -$20.2K |
|
|
DZSI
11423
DELISTED
DZS Inc. Common Stock
DZSI
| $64.4K | ﹤0.01% |
16,227
-234,852
| -94% | -$1.38M |
|
|
ASTR
11424
CALL
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
| $64.4K | ﹤0.01% |
11,647
-546
| -4% | -$3.12K |
|
11425
Gaia
GAIA
$37.1M
| $64.4K | ﹤0.01% |
27,873
-14,294
| -34% | -$39.7K |
|
Similar funds
Ken Griffin's Q2 2023 Portfolio in Review
As of Q2 2023, Ken Griffin held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Ken Griffin withdrew a net $16.6B in Q2 2023, closing 1,562 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Ken Griffin opened a new position in BILL Holdings worth $222M.
- Ken Griffin's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
- Ken Griffin added most to Microsoft in Q2 2023, an estimated $640M increase.
- Ken Griffin's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
- Ken Griffin fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
- Ken Griffin's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
- Ken Griffin opened 1,205 new positions and closed 1,562 in Q2 2023.
- Ken Griffin's portfolio value rose 6.4% quarter-over-quarter to $484B.
Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.